Correlation Between Jinhe Biotechnology and Ningbo MedicalSystem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and Ningbo MedicalSystem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and Ningbo MedicalSystem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jinhe Biotechnology Co and Ningbo MedicalSystem Biotechnology, you can compare the effects of market volatilities on Jinhe Biotechnology and Ningbo MedicalSystem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of Ningbo MedicalSystem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and Ningbo MedicalSystem.

Diversification Opportunities for Jinhe Biotechnology and Ningbo MedicalSystem

0.96
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Jinhe and Ningbo is 0.96. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and Ningbo MedicalSystem Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ningbo MedicalSystem and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with Ningbo MedicalSystem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ningbo MedicalSystem has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and Ningbo MedicalSystem go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and Ningbo MedicalSystem

Assuming the 90 days trading horizon Jinhe Biotechnology is expected to generate 1.79 times less return on investment than Ningbo MedicalSystem. But when comparing it to its historical volatility, Jinhe Biotechnology Co is 1.41 times less risky than Ningbo MedicalSystem. It trades about 0.05 of its potential returns per unit of risk. Ningbo MedicalSystem Biotechnology is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  966.00  in Ningbo MedicalSystem Biotechnology on September 1, 2024 and sell it today you would earn a total of  195.00  from holding Ningbo MedicalSystem Biotechnology or generate 20.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Jinhe Biotechnology Co  vs.  Ningbo MedicalSystem Biotechno

 Performance 
       Timeline  
Jinhe Biotechnology 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.
Ningbo MedicalSystem 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point.

Jinhe Biotechnology and Ningbo MedicalSystem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jinhe Biotechnology and Ningbo MedicalSystem

The main advantage of trading using opposite Jinhe Biotechnology and Ningbo MedicalSystem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, Ningbo MedicalSystem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ningbo MedicalSystem will offset losses from the drop in Ningbo MedicalSystem's long position.
The idea behind Jinhe Biotechnology Co and Ningbo MedicalSystem Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data